Trial Profile
Evaluation of Local Pharmacokinetics and Tolerability of Bimatoprost Applied Topically to the Scalp of Male Patients With Androgenetic Alopecia
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2016
Price :
$35
*
At a glance
- Drugs Bimatoprost (Primary)
- Indications Alopecia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Allergan
- 25 Oct 2016 Status changed from recruiting to completed.
- 02 Aug 2016 New trial record